Scholar Rock Holding has resubmitted its application for its spinal muscular atrophy treatment to the Food and Drug Administration. The biopharmaceutical company said that it has sent in a new ...
Lindsey Vonn is back on her feet after a wicked crash at the Olympics nearly cost her a leg. However, she suffered from ...
Full 12-month data from Ocugen’s phase 2 eye disease gene therapy show the therapy significantly reduces the size of lesions, ...
Biogen Inc. BIIB shares are up on Monday following the FDA’s approval of a new high-dose regimen for Spinraza (nusinersen), a ...
This high dose nusinersen regimen for spinal muscular atrophy includes 50mg loading doses and 28mg maintenance doses.
Discusses BLA Resubmission for Apitegromab in Spinal Muscular Atrophy and Regulatory Progress March 31, 2026 8:00 ...
As adherence to the Mediterranean-DASH Intervention for Neurodegenerative Delay diet went up, total grey matter decline and ...
In a phase 2 trial, OCU410, a modifier gene therapy for geographic atrophy secondary to dry age-related macular degeneration, ...
Alcohol consumption is one of the habits that can do the most harm to our health, especially to the brain and its neurons.
Muscle atrophy, as the name suggests, is a weakening or reduction of muscle due to lack of use or due to a disease. It is a result of a mismatch between the rates of protein synthesis and protein ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results